共 8 条
- [1] Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis [J]. PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (05):
- [3] Different liposomal amphotericin B formulations for visceral leishmaniasis [J]. LANCET GLOBAL HEALTH, 2014, 2 (08): : E449 - E449
- [6] Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia [J]. PLOS ONE, 2014, 9 (06):